Mitochondrial impairment activates the Wallerian pathway through depletion of NMNAT2 leading to SARM1-dependent axon degeneration
Andrea Loreto(The University of Sydney), Michael P. Coleman(Babraham Institute)
Cited by 10
Related Papers
Targeting NMNAT1 to Axons and Synapses Transforms Its Neuroprotective Potency<i>In Vivo</i>
|Journal of Neuroscience|2010|123
Alzheimer’s Disease: Etiology, Neuropathology and Pathogenesis
|Exon Publications eBooks|2020|93
NMNAT2 is a druggable target to drive neuronal NAD production
|Nature Communications|2024|36
SARM1 activation induces reversible mitochondrial dysfunction and can be prevented in human neurons by antisense oligonucleotides
|bioRxiv (Cold Spring Harbor Laboratory)|2024|5